Wei Ling, Xiao Ying, Li Li, Xiong Xiaofen, Han Yachun, Zhu Xuejing, Sun Lin
Department of Nephrology, Second Xiangya Hospital, Central South University, Changsha, China.
Kidney Dis (Basel). 2018 Nov;4(4):226-237. doi: 10.1159/000492633. Epub 2018 Sep 6.
Diabetes mellitus (DM) poses a severe threat to global public health. Diabetic nephropathy (DN) is one of the most common complications of diabetes and the leading cause of end-stage renal disease (ESRD). Approximately 30-40% of DM patients in the world progress to ESRD, which emphasizes the effect of genetic factors on DN. Family clustering also supports the important role of hereditary factors in DN and ESRD. Therefore, a large number of genetic studies have been carried out to identify susceptibility genes in different diabetic cohorts. Extensive susceptibility genes of DN and ESRD have not been identified until recently.
Some of these associated genes function as pivotal regulators in the pathogenesis of DN, such as those related to glycometabolism and lipid metabolism. However, the functions of most of these genes remain unclear. In this article, we review several susceptibility genes according to their genetic functions to make it easier to determine their exact effect on DN and to provide a better understanding of the advancements from genetic studies. However, several challenges associated with investigating the genetic factors of DN still exist. For instance, it is difficult to determine whether these variants affect the expression of the protein they encode or other cytokines. More efforts should be made to determine how these genes influence the progression of DN. In addition, many results could not be replicated among races, suggesting that the association between genetic polymorphisms and DN is race-specific. Therefore, large, well-designed studies involving more relevant variables and ethnic groups and more relevant functional studies are urgently needed. These studies may be beneficial and retard the progression of DN by early intervention, especially for patients who carry certain risk alleles or genotypes.
糖尿病(DM)对全球公共卫生构成严重威胁。糖尿病肾病(DN)是糖尿病最常见的并发症之一,也是终末期肾病(ESRD)的主要原因。全球约30 - 40%的糖尿病患者会发展为ESRD,这凸显了遗传因素对DN的影响。家族聚集性也支持遗传因素在DN和ESRD中的重要作用。因此,已经开展了大量的遗传学研究来确定不同糖尿病队列中的易感基因。直到最近,DN和ESRD广泛的易感基因仍未被确定。
其中一些相关基因在DN的发病机制中起关键调节作用,例如那些与糖代谢和脂代谢相关的基因。然而,这些基因中的大多数功能仍不清楚。在本文中,我们根据它们的遗传功能综述了几个易感基因,以便更易于确定它们对DN的确切影响,并更好地理解遗传学研究的进展。然而,与研究DN遗传因素相关的几个挑战仍然存在。例如,很难确定这些变异是否影响它们所编码蛋白质或其他细胞因子的表达。应该做出更多努力来确定这些基因如何影响DN的进展。此外,许多结果在不同种族之间无法重复,这表明基因多态性与DN之间的关联具有种族特异性。因此,迫切需要开展涉及更多相关变量和种族群体的大型、设计良好的研究以及更多相关的功能研究。这些研究可能有益,并通过早期干预延缓DN的进展,特别是对于携带某些风险等位基因或基因型的患者。